Recall: D-0371-2023
Class II - Potentially Harmful
Class IIClassification
2023-02-07Initiated
TerminatedStatus
Accord Healthcare, Inc.Firm
Product
Atorvastatin Calcium Tablets USP, 10 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-044-15 UPC 3 16729 04415 8; b) 1,000 Tablets NDC 16729-044-17 UPC 3 16729 04417 2; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA.
Reason
CGMP Deviations: recalling drug products following an FDA inspection.
Distribution
United States including Puerto Rico and Canada
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.